Your browser doesn't support javascript.
loading
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).
Cardoso, F; Costa, A; Norton, L; Senkus, E; Aapro, M; André, F; Barrios, C H; Bergh, J; Biganzoli, L; Blackwell, K L; Cardoso, M J; Cufer, T; El Saghir, N; Fallowfield, L; Fenech, D; Francis, P; Gelmon, K; Giordano, S H; Gligorov, J; Goldhirsch, A; Harbeck, N; Houssami, N; Hudis, C; Kaufman, B; Krop, I; Kyriakides, S; Lin, U N; Mayer, M; Merjaver, S D; Nordström, E B; Pagani, O; Partridge, A; Penault-Llorca, F; Piccart, M J; Rugo, H; Sledge, G; Thomssen, C; Van't Veer, L; Vorobiof, D; Vrieling, C; West, N; Xu, B; Winer, E.
Affiliation
  • Cardoso F; European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt.
  • Costa A; European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland.
  • Norton L; Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA.
  • Senkus E; Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
  • Aapro M; Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland.
  • André F; Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France.
  • Barrios CH; Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil.
  • Bergh J; Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden.
  • Biganzoli L; Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy.
  • Blackwell KL; Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA.
  • Cardoso MJ; Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal.
  • Cufer T; University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia.
  • El Saghir N; NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon.
  • Fallowfield L; Brighton & Sussex Medical School, University of Sussex, Falmer, UK.
  • Fenech D; Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta.
  • Francis P; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Gelmon K; BC Cancer Agency, Vancouver, Canada.
  • Giordano SH; Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA.
  • Gligorov J; APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, Arome, Paris, France.
  • Goldhirsch A; Program of Breast Health, European Institute of Oncology, Milan, Italy.
  • Harbeck N; Brustzentrum der Universität München, Munich, DE, USA.
  • Houssami N; Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia.
  • Hudis C; Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA.
  • Kaufman B; Sheba Medical Center, Tel Hashomer, Israel.
  • Krop I; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Kyriakides S; Europa Donna Cyprus, Nicosa, Cyprus.
  • Lin UN; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Mayer M; Advanced BC.org, New York, USA.
  • Merjaver SD; University of Michigan Medical School and School of Public Health, Ann Arbor, USA.
  • Nordström EB; Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden.
  • Pagani O; Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland.
  • Partridge A; Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA.
  • Penault-Llorca F; Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France.
  • Piccart MJ; Department of Medicine, Institut Jules Bordet, Brussels, Belgium.
  • Rugo H; Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
  • Sledge G; Indiana University Medical CTR, Indianapolis, USA.
  • Thomssen C; Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany.
  • Van't Veer L; Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
  • Vorobiof D; Sandton Oncology Centre, Johannesburg, South Africa.
  • Vrieling C; Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland.
  • West N; Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK.
  • Xu B; Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Winer E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
Breast ; 23(5): 489-502, 2014 Oct.
Article de En | MEDLINE | ID: mdl-25244983
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein Type d'étude: Guideline Aspects: Patient_preference Limites: Female / Humans Langue: En Journal: Breast Sujet du journal: ENDOCRINOLOGIA / NEOPLASIAS Année: 2014 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein Type d'étude: Guideline Aspects: Patient_preference Limites: Female / Humans Langue: En Journal: Breast Sujet du journal: ENDOCRINOLOGIA / NEOPLASIAS Année: 2014 Type de document: Article